No Data
No Data
Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
MIAMI, July 05, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO, FBIOP)) ("Fortress"), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for
Checkpoint Therapeutics Announces Alignment With FDA Enabling Upcoming Cosibelimab BLA Resubmission
Fortress Biotech Inc Series A P To Go Ex-Dividend On June 14th, 2024 With 0.19531 USD Dividend Per Share
June 8th - $Fortress Biotech Inc Series A P(FBIOP.US)$ is trading ex-dividend on June 14th, 2024. Shareholders of record on June 15th, 2024 will receive 0.19531 USD dividend per share on June 30th
10-Q: Quarterly report
Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech Inc Series A P To Go Ex-Dividend On May 14th, 2024 With 0.19531 USD Dividend Per Share
May 9th - $Fortress Biotech Inc Series A P(FBIOP.US)$ is trading ex-dividend on May 14th, 2024. Shareholders of record on May 15th, 2024 will receive 0.19531 USD dividend per share on May 31st, 20
No Data